Zebra Capital Management LLC Corcept Therapeutics Inc Transaction History

Zebra Capital Management LLC

$20 Million
Q1 2023

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $188,243 - $287,091	-11,388 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $71,785 - $97,981	-4,198 Reduced 26.93%	11,388 $225,000
Q3 2021 Nov 15, 2021	BUY	$19.68 - $22.53 $306,732 - $351,152	15,586 New	15,586 $307,000
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $1.1 Million - $1.44 Million	-46,989 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$16.78 - $27.3 $29,465 - $47,938	1,756 Added 3.88%	46,989 $1.23 Million
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $143,165 - $229,570	11,490 Added 34.05%	45,233 $787,000
Q2 2020 Aug 14, 2020	SELL	$11.0 - $18.26 $42,933 - $71,268	-3,903 Reduced 10.37%	33,743 $568,000
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $9,725 - $13,506	-962 Reduced 2.49%	37,646 $448,000
Q4 2019 Feb 14, 2020	BUY	$12.06 - $16.96 $159,179 - $223,855	13,199 Added 51.95%	38,608 $467,000
Q3 2019 Nov 14, 2019	SELL	$10.41 - $14.66 $143,637 - $202,278	-13,798 Reduced 35.19%	25,409 $359,000
Q2 2019 Aug 14, 2019	BUY	$9.78 - $12.76 $16,508 - $21,538	1,688 Added 4.5%	39,207 $437,000
Q1 2019 May 15, 2019	BUY	$10.03 - $15.71 $52,456 - $82,163	5,230 Added 16.2%	37,519 $440,000
Q4 2018 Feb 14, 2019	SELL	$11.29 - $17.19 $163,005 - $248,189	-14,438 Reduced 30.9%	32,289 $431,000
Q3 2018 Nov 14, 2018	SELL	$12.27 - $15.65 $128,246 - $163,573	-10,452 Reduced 18.28%	46,727 $655,000
Q2 2018 Aug 14, 2018	SELL	$15.3 - $19.69 $85,175 - $109,614	-5,567 Reduced 8.87%	57,179 $899,000
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $125,284 - $218,968	8,587 Added 15.86%	62,746 $1.03 Million
Q4 2017 Feb 14, 2018	BUY	$15.77 - $20.72 $319,626 - $419,952	20,268 Added 59.8%	54,159 $978,000
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $416,859 - $654,096	33,891	33,891 $654,000

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

Black Rock Inc. New York, NY

16.5M
Shares

$824 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$499 Million
0.01% of portfolio
Ingalls & Snyder LLC New York, NY

8.27M
Shares

$412 Million
14.93% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

6.51M
Shares

$324 Million
0.48% of portfolio
Parallel Advisors, LLC

3.81M
Shares

$190 Million
4.22% of portfolio

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.34B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.

Account